Biotech Series A Investors & VC Firms
1626 firms in this list, with a median first check of $500K. 369 of them lead rounds. Generated from verified public data and updated continuously.
Cardinal Partners
PrincetonSeed–Growth
11 people
Living Lab Ventures
TangerangPre-Seed–Series A
8 people
Neulogy Ventures
LuxembourgSeed–Series A$216K – $3.2M
5 people
PhotonVentures
HilversumSeed–Series A$1.1M – $2.7M
8 people
Artemis Growth Partners
LondonSeed–Series B
1 person
Happiness Capital
Hong KongSeed–Growth
7 people
CABHI Ventures
TorontoPre-Seed–Series A
9 people
Iron Wolf Capital
VilniusSeed–Series A$550K – $5.5M
6 people
NSG Ventures
SingaporeSeed–Series A
9 people
Salveo Capital
NorthbrookSeed–Growth
9 people
Presight Capital
SliemaPre-Seed–Growth$500K – $20M
4 people
Ascenta Capital
WilmingtonSeed–Series B$15M – $30M
8 people
Blindspot Ventures Management Co
BostonPre-Seed–Series B
5 people
Medical Incubator Japan K.K.
TokyoSeries A–Series B
11 people
Radix Ventures
SenningerbergSeed–Growth$550K – $2.8M
11 people
Biovance Capital Partners SCR
LisbonSeed–Series A
16 people
CITES
SunchalesPre-Seed–Series A$3.5M
10 people
Morgenthaler
Portola ValleyPre-Seed–Series C
8 people
Artiman Ventures
Palo AltoSeed–Series A$2M – $6M
9 people
Fab Co-Creation Studio Ventures
San FranciscoPre-Seed–Series A$250K – $1M
3 people
Logos
San FranciscoSeries A–Series B
15 people
Prospect Venture Partners
Menlo ParkSeed–Late Stage$3M – $5M
3 people
Detong Capital
ShanghaiSeed–Growth$20M
11 people
ATOORO FUND
Tel AvivPre-Seed–Series A$500K – $5M
2 people
Related lists
Series A Investors & VC Firms (7325)Series A Investors & VC Firms in North America (4219)Series A Investors & VC Firms in United States (3838)AI & Machine Learning Series A Investors & VC Firms (2601)SaaS Series A Investors & VC Firms (2590)Biotech Investors & VC Firms (2475)Series A Investors & VC Firms in Europe (2383)Fintech Series A Investors & VC Firms (2349)Healthtech Series A Investors & VC Firms (2309)Enterprise Software Series A Investors & VC Firms (2264)
Data sourced from public filings and firms' own websites — see our methodology.
























































































